153 related articles for article (PubMed ID: 24394737)
1. Incidence of hypersensitivity skin reactions in patients on full-dose low-molecular-weight heparins during pregnancy.
Schultinge L; Knol HM; Kluin-Nelemans HC; Erwich JJ; Meijer K
Neth J Med; 2013 Dec; 71(10):518-22. PubMed ID: 24394737
[TBL] [Abstract][Full Text] [Related]
2. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
Galambosi PJ; Ulander VM; Kaaja RJ
Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
[TBL] [Abstract][Full Text] [Related]
3. The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy.
Knol HM; Schultinge L; Veeger NJ; Kluin-Nelemans HC; Erwich JJ; Meijer K
Thromb Res; 2012 Sep; 130(3):334-8. PubMed ID: 22475315
[TBL] [Abstract][Full Text] [Related]
4. Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study.
Galambosi PJ; Kaaja RJ; Stefanovic V; Ulander VM
Eur J Obstet Gynecol Reprod Biol; 2012 Aug; 163(2):154-9. PubMed ID: 22658765
[TBL] [Abstract][Full Text] [Related]
5. Prevention and management of venous thromboembolism in pregnancy.
James AH
Am J Med; 2007 Oct; 120(10 Suppl 2):S26-34. PubMed ID: 17916457
[TBL] [Abstract][Full Text] [Related]
6. Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids.
Gerhardt A; Zotz RB; Stockschlaeder M; Scharf RE
Thromb Haemost; 2007 Mar; 97(3):496-7. PubMed ID: 17334521
[No Abstract] [Full Text] [Related]
7. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.
Duhl AJ
J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy.
Ní Ainle F; Wong A; Appleby N; Byrne B; Regan C; Hassan T; Milner M; Sullivan AO; White B; O'Donnell J
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):689-92. PubMed ID: 18832911
[TBL] [Abstract][Full Text] [Related]
9. Management of thromboembolism in pregnancy.
Marks PW
Semin Perinatol; 2007 Aug; 31(4):227-31. PubMed ID: 17825678
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
11. Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density.
Galambosi P; Hiilesmaa V; Ulander VM; Laitinen L; Tiitinen A; Kaaja R
Thromb Res; 2016 Jul; 143():122-6. PubMed ID: 27236710
[TBL] [Abstract][Full Text] [Related]
12. Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis.
Thachil J
Ann Pharmacother; 2014 Mar; 48(3):420-4. PubMed ID: 24473488
[TBL] [Abstract][Full Text] [Related]
13. [Thromboprophylaxis with low-molecular-weight heparin insufficient in high-risk pregnancy].
Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
Ned Tijdschr Geneeskd; 2011; 155():A3433. PubMed ID: 21527059
[TBL] [Abstract][Full Text] [Related]
14. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight heparins: a guide to their optimum use in pregnancy.
Laurent P; Dussarat GV; Bonal J; Jego C; Talard P; Bouchiat C; Cellarier G
Drugs; 2002; 62(3):463-77. PubMed ID: 11827560
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of venous thromboembolism in pregnancy.
James AH
Clin Obstet Gynecol; 2012 Sep; 55(3):774-87. PubMed ID: 22828110
[TBL] [Abstract][Full Text] [Related]
17. The use of unfractionated heparin and low molecular weight heparins in pregnancy.
Casele HL
Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684
[TBL] [Abstract][Full Text] [Related]
18. Association between prophylactic low-molecular-weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort.
Lowry DE; Corsi DJ; White RR; Guo M; Lanes A; Smith G; Rodger M; Wen SW; Walker M; Gaudet L
J Thromb Haemost; 2019 Feb; 17(2):345-349. PubMed ID: 30552749
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
20. Adverse skin reactions to low molecular weight heparins: frequency, management and prevention.
Wütschert R; Piletta P; Bounameaux H
Drug Saf; 1999 Jun; 20(6):515-25. PubMed ID: 10392668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
